Anesthesia for TORS for Oropharyngeal Carcinoma: Factors Associated with Prolonged Phase I Postanesthesia Recovery

被引:4
|
作者
Puccinelli, Cassandra L. [1 ]
Moore, Eric J. [1 ]
Yin, Linda X. [1 ]
Price, Daniel L. [1 ]
Janus, Jeffrey R. [1 ]
Weingarten, Toby N. [2 ]
Van Abel, Kathryn M. [1 ]
机构
[1] Mayo Clin, Dept Otolaryngol Head & Neck Surg, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA
关键词
transoral robotic surgery; TORS; oropharynx cancer; nausea; vomiting; pain; anesthesia; phase I; PACU; TRANSORAL ROBOTIC SURGERY; POSTOPERATIVE NAUSEA; HUMAN-PAPILLOMAVIRUS; RESPIRATORY DEPRESSION; PLUS ONDANSETRON; PAIN MANAGEMENT; CARE-UNIT; DEXAMETHASONE; COMBINATION; PREVENTION;
D O I
10.1177/0194599820915529
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives Clinical variables affecting anesthetic recovery following transoral robotic surgery (TORS) to resect oropharyngeal squamous cell carcinoma have not been described. We aimed to explore risk factors associated with prolonged postanesthesia recovery following TORS. Study Design Retrospective case-control study. Setting Tertiary referral center, January 2010 to November 2016. Subjects and Methods Patients included adults undergoing primary TORS +/- neck dissection for oropharyngeal squamous cell carcinoma. Patients were categorized by phase I recovery time into the "goal" recovery group (75th percentile [lower 3 quartiles], n = 272) and the "prolonged" recovery group (n = 91). Univariate and multivariate logistic regression analyses were performed to assess the associations between clinical characteristics and prolonged phase I recovery. Results A total of 363 patients were included. Median (interquartile range) duration of postanesthesia recovery was 1.5 hours (1.0-2.0). Prolonged recovery was associated with isoflurane (odds ratio, 2.83 [95% CI, 1.56-5.14], P < .001), midazolam (2.77 [1.50-5.12], P = .001), and larger opioid doses (1.26 [1.01-1.58] per 10-mg intravenous morphine equivalents, P = .040) and inversely associated with multimodal antiemetic therapy (0.34 [0.15-0.78], P = .011). Prolonged cases had higher rates of postoperative nausea and vomiting (n = 43 [47.2%] vs 86 [31.6%], P = .008), respiratory depression (28 [30.8%] vs 12 [4.4%], P < .001), sedation (Richmond Agitation-Sedation Scale < -2; 26 [28.6%] vs 35 [12.9%], P = .001), severe pain (numeric rating score >= 7; 31 [34.4%] vs 45 [17.2%], P = .001), and longer hospital stays (4 vs 3 days, P < .001). Conclusions Several anesthetic factors are associated with anesthesia recovery duration, which may be shortened by efforts to reduce postoperative sedation, severe pain, and nausea/vomiting. Shortened anesthesia recovery time may reduce hospital stay.
引用
收藏
页码:531 / 537
页数:7
相关论文
共 50 条
  • [41] CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma
    Song, Bolin
    Yang, Kailin
    Viswanathan, Vidya Sankar
    Wang, Xiangxue
    Lee, Jonathan
    Stock, Sarah
    Fu, Pingfu
    Lu, Cheng
    Koyfman, Shlomo
    Lewis, James S.
    Madabhushi, Anant
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [42] CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma
    Bolin Song
    Kailin Yang
    Vidya Sankar Viswanathan
    Xiangxue Wang
    Jonathan Lee
    Sarah Stock
    Pingfu Fu
    Cheng Lu
    Shlomo Koyfman
    James S. Lewis
    Anant Madabhushi
    npj Precision Oncology, 7
  • [43] Assessing the Role of Clinicopathologic Factors in Outcome Prediction in Subjects Having Oropharyngeal Carcinoma Associated with Human Papillomavirus and Managed with Surgery
    Kumar, Harsh
    Sandhu, Rameet
    Upadhyay, Ritesh
    Aggarwal, Aanchal
    Rela, Rathi
    Karthik, Sahana
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2024, 16 (SUPPL 4) : S4091 - S4093
  • [44] Long-Term Prognosis and Risk Factors Among Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma
    Lin, Brian M.
    Wang, Hao
    D'Souza, Gypsyamber
    Zhang, Zhe
    Fakhry, Carole
    Joseph, Andrew W.
    Drake, Virginia E.
    Sanguineti, Giuseppe
    Westra, William H.
    Pai, Sara I.
    CANCER, 2013, 119 (19) : 3462 - 3471
  • [45] PRECISION REHABILITATION FOR MILD TRAUMATIC BRAIN INJURY: DEVELOPING TREATMENTS THAT TARGET RISK FACTORS ASSOCIATED WITH PROLONGED RECOVERY
    Cairncross, Molly
    ANNALS OF BEHAVIORAL MEDICINE, 2021, 55 : S602 - S602
  • [46] A Prospective Phase II Trial of Deintensified Chemoradiation Therapy for Low Risk HPV Associated Oropharyngeal Squamous Cell Carcinoma
    Chera, B. S.
    Amdur, R. J.
    Tepper, J. E.
    Qaqish, B.
    Green, R.
    Hayes, N. N.
    Weiss, J.
    Grilley-Olson, J.
    Zanation, A.
    Hackman, T.
    Funkhouser, W.
    Sheets, N. C.
    Weissler, M.
    Mendenhall, W. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S2 - S2
  • [47] Primary chemoradiotherapy or transoral robotic surgery for Stage I-II HPV-associated oropharyngeal squamous cell carcinoma
    Hughes, R. T.
    May, N.
    Waltonen, J. D.
    Porosnicu, M.
    Lycan, T.
    Sullivan, C. A.
    Patwa, H. S.
    Shenker, R. F.
    Frizzell, B. A.
    Greven, K. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1120 - 1120
  • [48] Factors Associated with Inclusion of Japan in Phase I Multiregional Clinical Trials in Oncology
    Maki, Akio
    Narukawa, Mamoru
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (04) : 766 - 772
  • [49] Phase II Study of Radiation Volume and Dose De-Intensification Following Tors and Neck Dissection for p16+Oropharyngeal Squamous Cell Carcinoma - Long-Term Results of Expanded Cohort
    Lukens, J. N.
    MacDuffie, E.
    Siegal, T.
    Poirier, K.
    Weinstein, G.
    Newman, J. G.
    Chalian, A.
    Brody, R.
    Rajasekaran, K.
    Cannady, S. B.
    Basu, D.
    Rassekh, C.
    Montone, K.
    Sun, L.
    Singh, A.
    Cohen, R.
    Maxwell, R. J. L.
    Gentile, M. S.
    Lin, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S121 - S121
  • [50] Assessment of bacterial positivity rate changes in anesthesia machine internal circuits within recovery rooms and associated risk factors
    Zhang, Shuxiao
    Ge, Jingwu
    Zhou, Xuelong
    Ji, Yanhong
    Hong, Junjie
    Xu, Wensu
    Li, Tonglai
    BMC ANESTHESIOLOGY, 2025, 25 (01):